BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19551763)

  • 1. Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Hum Psychopharmacol; 2009 Jul; 24(5):415-22. PubMed ID: 19551763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Psychiatry Res; 2010 Apr; 176(2-3):114-9. PubMed ID: 20199813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.
    Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA
    J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.
    Fleischhaker C; Schulz E; Remschmidt H
    J Psychiatr Res; 1998; 32(5):325-33. PubMed ID: 9789212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
    Sumiyoshi T; Jayathilake K; Meltzer HY
    Schizophr Res; 2003 Jan; 59(1):7-16. PubMed ID: 12413636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs.
    Meltzer HY; Koenig JI; Nash JF; Gudelsky GA
    Acta Psychiatr Scand Suppl; 1989; 352():24-9. PubMed ID: 2573238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melperone in the treatment of neuroleptic-resistant schizophrenia.
    Meltzer HY; Sumiyoshi T; Jayathilake K
    Psychiatry Res; 2001 Dec; 105(3):201-9. PubMed ID: 11814539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical neuroleptics, pharmacology and clinical importance].
    Klages U; Hippius H; Müller-Spahn F
    Fortschr Neurol Psychiatr; 1993 Nov; 61(11):390-8. PubMed ID: 7903656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine reduces rehospitalization among schizophrenia patients.
    Pollack S; Woerner MG; Howard A; Fireworker RB; Kane JM
    Psychopharmacol Bull; 1998; 34(1):89-92. PubMed ID: 9564204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible levomepromazine-clozapine interaction: two case reports.
    Bugamelli F; Mandrioli R; Kenndler E; Bartoletti C; Boncompagni G; Raggi MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):567-70. PubMed ID: 17174461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential neuroleptic treatment of schizophrenic psychoses in puerperium: advantages of the atypical neuroleptic clozapine].
    Weller M; Kornhuber J
    Nervenarzt; 1992 Jul; 63(7):440-1. PubMed ID: 1501722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response to clozapine.
    Lieberman JA; Kane JM; Safferman AZ; Pollack S; Howard A; Szymanski S; Masiar SJ; Kronig MH; Cooper T; Novacenko H
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():126-8. PubMed ID: 7961556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics.
    Casey DE
    Psychopharmacol Bull; 1991; 27(1):47-50. PubMed ID: 1677773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin.
    Tripodianakis J; Markianos M; Garelis E
    Biol Psychiatry; 1983 Mar; 18(3):337-45. PubMed ID: 6132625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients.
    Christensen I; Geismar L; Kirkegaard A; Kirkegaard G
    Arzneimittelforschung; 1986 May; 36(5):855-60. PubMed ID: 2873821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia.
    Schulz E; Fleischhaker C; Remschmidt HE
    J Child Adolesc Psychopharmacol; 1996; 6(2):119-31. PubMed ID: 9231304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sedative effects and prolactin response to single oral doses of melperone.
    Molander L; Borgström L
    Psychopharmacology (Berl); 1983; 79(2-3):142-7. PubMed ID: 6133301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients.
    Kirkegaard A; Kirkegaard G; Geismar L; Christensen I
    Arzneimittelforschung; 1981; 31(4):737-40. PubMed ID: 6113835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
    Poyraz BC; Aksoy C; Balcioğlu I
    Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.